A Study of Nal-IRI With 5-FU, Levofolinic Acid and Oxaliplatin in Patients With Resectable Pancreatic Cancer
Clinical trial NCT03528785 · UNKNOWN
Trial details
- NCT number
- NCT03528785
- Sponsor
- Centro Ricerche Cliniche di Verona
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-02
- Primary completion
- 2021-11-15
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.